Advanced Medical Solutions Group (LON:AMS) Given Buy Rating at Deutsche Bank Aktiengesellschaft

Advanced Medical Solutions Group (LON:AMS - Get Free Report)'s stock had its "buy" rating restated by analysts at Deutsche Bank Aktiengesellschaft in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. They presently have a GBX 275 ($3.69) target price on the stock. Deutsche Bank Aktiengesellschaft's price objective would indicate a potential upside of 31.89% from the stock's current price.

Separately, Berenberg Bank restated a "buy" rating and set a GBX 300 ($4.03) target price on shares of Advanced Medical Solutions Group in a research report on Tuesday.

Advanced Medical Solutions Group Stock Up 0.7%

Advanced Medical Solutions Group stock traded up GBX 1.50 ($0.02) during trading hours on Wednesday, hitting GBX 208.50 ($2.80). The stock had a trading volume of 2,858,704 shares, compared to its average volume of 937,393. The company has a quick ratio of 4.58, a current ratio of 8.39 and a debt-to-equity ratio of 37.01. The stock has a market capitalization of £450.21 million, a P/E ratio of 40.40, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. Advanced Medical Solutions Group has a 12-month low of GBX 168.40 ($2.26) and a 12-month high of GBX 275.83 ($3.70). The stock's 50-day moving average price is GBX 204.59 and its 200-day moving average price is GBX 204.52.

Insider Activity

In related news, insider A Christopher (Chris) Meredith sold 64,000 shares of Advanced Medical Solutions Group stock in a transaction dated Monday, May 12th. The shares were sold at an average price of GBX 195 ($2.62), for a total transaction of £124,800 ($167,584.26). Also, insider Eddie Johnson sold 16,402 shares of Advanced Medical Solutions Group stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of GBX 195 ($2.62), for a total transaction of £31,983.90 ($42,948.70). Insiders sold a total of 435,255 shares of company stock valued at $84,691,330 in the last 90 days. Company insiders own 3.12% of the company's stock.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.